- Home
- RNAZ vs ISPC Comparison
RNAZ vs ISPC Comparison
Compare RNAZ & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNAZ | ISPC |
|---|---|---|
| Founded | 2016 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 5.7M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RNAZ | ISPC |
|---|---|---|
| Price | $7.31 | $0.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $280.00 | N/A |
| AVG Volume (30 Days) | 19.1K | ★ 1.5M |
| Earning Date | 11-14-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,352,744.00 |
| Revenue This Year | N/A | $35.93 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.08 | $0.26 |
| 52 Week High | $468.44 | $3.38 |
Technical Indicators
Market Signals| Indicator | RNAZ | ISPC |
|---|---|---|
| Relative Strength Index (RSI) | 45.84 | 26.71 |
| Support Level | $6.08 | $0.36 |
| Resistance Level | $7.67 | $0.37 |
| Average True Range (ATR) | 0.80 | 0.05 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 47.38 | 14.83 |
Price Performance
Historical ComparisonAbout RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.